30 NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) changes as a predictor of eventual treatment failure and death on nivolumab therapy in renal cell carcinoma

Bibliographic Details
Main Authors: Arnab Basu, Eddy Yang, Yash Suri, Lakshminarayan Nandagopal, Mollie Deshazo, Lyse Norian
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items